Enlivex (ENLV) Exchange Rate Effect (2016 - 2021)
Enlivex (ENLV) posted quarterly Exchange Rate Effect of $249000.0 for Q4 2021, down 12.32% year-over-year from $284000.0 in Q4 2020, and up 155.7% quarter-over-quarter from -$447000.0 in Q3 2021.
Enlivex (ENLV) Exchange Rate Effect (2016 - 2021) Analysis & Trends
Enlivex's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $249000.0 for Q4 2021.
- In Q4 2021, Exchange Rate Effect fell 12.32% year-over-year to $249000.0; the TTM figure through Dec 2021 stood at -$408000.0 (down 204.62% YoY), while the FY2021 annual figure was -$408000.0, down 204.62% from the prior year.
- Exchange Rate Effect for Q4 2021 stood at $249000.0, up from -$447000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $4.1 million in Q1 2017, with the low at -$5.0 million in Q3 2017.
- The 5-year median for Exchange Rate Effect is $198500.0 (2017), against an average of $20100.0.
- The sharpest annual moves came in 2019 and 2020: Exchange Rate Effect soared 950.0% in 2019, then plunged 449.83% in 2020.
- Enlivex's Exchange Rate Effect stood at $167000.0 in 2017, then plunged by 301.2% to -$336000.0 in 2018, then soared by 85.42% to -$49000.0 in 2019, then jumped by 679.59% to $284000.0 in 2020, then slipped by 12.32% to $249000.0 in 2021.
- Business Quant data shows ENLV's Exchange Rate Effect at $249000.0 in Q4 2021, -$447000.0 in Q3 2021, and $389000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Enlivex | 4.58 Mn | -1.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 249,000.00 |
| Dec 31, 2021 | 249,000.00 |
| Sep 30, 2021 | -447,000.00 |
| Sep 30, 2021 | -447,000.00 |
| Jun 30, 2021 | 389,000.00 |
| Jun 30, 2021 | 389,000.00 |
| Mar 31, 2021 | -599,000.00 |
| Mar 31, 2021 | -599,000.00 |
| Dec 31, 2020 | 284,000.00 |
| Dec 31, 2020 | 284,000.00 |
| Sep 30, 2020 | 230,000.00 |
| Sep 30, 2020 | 230,000.00 |
| Jun 30, 2020 | 929,000.00 |
| Jun 30, 2020 | 929,000.00 |
| Mar 31, 2020 | -1.05 Mn |
| Mar 31, 2020 | -1.05 Mn |
| Dec 31, 2019 | -49,000.00 |
| Dec 31, 2019 | -49,000.00 |
| Sep 30, 2019 | 340,000.00 |
| Sep 30, 2019 | 340,000.00 |